Not all weight loss peptides work the same way. Some suppress appetite. Others increase fat oxidation at the cellular level. Some target visceral fat specifically, while others work by boosting metabolic rate. Understanding which compounds do what — and which combinations produce the best results — is the difference between a protocol that works and one that doesn't.
This guide covers every major peptide and compound available for weight loss through Verum Health, how each works, who it's for, and how to stack them intelligently.
Best for: Significant weight loss (15–20%+ body weight). The most clinically powerful option available.
How it works: GLP-1 receptor agonists mimic the gut hormone glucagon-like peptide-1, signaling satiety to the brain, slowing gastric emptying, and improving insulin sensitivity. Tirzepatide adds GIP (glucose-dependent insulinotropic polypeptide) receptor agonism, producing even greater weight loss in clinical trials — up to 22.5% average body weight reduction.
Who it's for: BMI ≥ 27 with comorbidities, or BMI ≥ 30. Anyone who has struggled to lose weight through diet and exercise alone.
Best for: Targeted fat loss, particularly stubborn abdominal fat. Often stacked with GLP-1s for enhanced results.
How it works: AOD-9604 is a modified fragment of human growth hormone (hGH 176–191) that specifically activates fat metabolism without the growth-promoting or insulin-disrupting effects of full HGH. It stimulates lipolysis (fat breakdown) and inhibits lipogenesis (fat storage) through beta-3 adrenergic receptors — essentially giving your body a direct signal to burn stored fat.
Protocol: 300mcg daily via subcutaneous injection or 300mcg oral troche. Best taken in the morning on an empty stomach. Results typically appear within 4–6 weeks.
Best for: Reducing visceral (deep abdominal) fat. FDA-approved for HIV-related lipodystrophy; used off-label for visceral fat reduction and metabolic optimization.
How it works: Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH). It stimulates the pituitary gland to produce more natural GH, which in turn promotes visceral fat mobilization. Unlike direct HGH, it works through the body's own feedback mechanisms — producing a more physiological response with better safety profile.
Results: Clinical trials show 15–20% reduction in visceral fat volume over 6 months. Improved waist circumference, better insulin sensitivity, and favorable lipid changes.
Best for: Metabolic optimization, insulin sensitivity, exercise performance enhancement, and weight loss in patients with metabolic dysfunction.
How it works: MOTS-C is a mitochondria-derived peptide that activates AMPK (AMP-activated protein kinase), the same pathway triggered by intense exercise. It improves glucose uptake in muscle, reduces fat accumulation, and increases cellular energy expenditure — essentially reproducing some of the metabolic benefits of exercise at the mitochondrial level.
Animal studies show prevention of diet-induced obesity and reversal of insulin resistance. Human protocols typically use 2–10mg doses depending on the goal.
Best for: Stubborn fat, especially for patients who have plateaued on other protocols. Powerful adjunct to GLP-1 therapy.
How it works: 5-Amino-1MQ inhibits the enzyme NNMT (nicotinamide N-methyltransferase), which plays a central role in fat cell metabolism. By blocking NNMT, it essentially "wakes up" dormant fat cells, converting them from energy-storing to energy-burning. Research shows significant reduction in fat mass without muscle loss.
| Compound | Mechanism | Expected Loss | Best For | Starting Price |
|---|---|---|---|---|
| Semaglutide | GLP-1 agonist, appetite | 15–20% BW | All patients | $120/mo |
| Tirzepatide | GLP-1 + GIP dual agonist | 20–22% BW | Max weight loss | $170/mo |
| AOD-9604 | Lipolysis activation | Adjunct fat loss | Stubborn fat | $160/5ML |
| Tesamorelin | GHRH analogue, visceral fat | 15–20% visceral | Belly fat | $200/5ML |
| MOTS-C | AMPK activation | Metabolic support | Metabolic dysfunction | $160/5ML |
| 5-Amino-1MQ | NNMT inhibitor | Fat cell activation | Plateau-breaker | $160/5ML |
For patients seeking maximum results, Verum Health's full metabolic protocol combines the top compounds into a synergistic stack: AOD-9604 + MOTS-C + Tesamorelin + Ipamorelin. Each component targets a different aspect of metabolism — fat mobilization, mitochondrial efficiency, visceral fat reduction, and growth hormone optimization — producing results that no single compound can match alone.
All four compounds in a single vial. Most cost-effective option for comprehensive metabolic support. View full protocol →
Disclaimer: These statements have not been evaluated by the FDA. Prescription required. Individual results may vary. This article is informational only and does not constitute medical advice.
Physician-reviewed in 24–48 hours. All compounds prescription-grade, pharmacy-dispensed.